RocapineIndependently confirmed
Rocapine scales wellness apps that “hold instead of hook”.
The round
Rocapine, a Paris-based company focused on scaling wellness applications, has successfully closed a Series A funding round, securing EUR 11.2 million. The lead investor for this round was not disclosed, nor were any other participating investors. The company’s valuation following this investment remains undisclosed.
What Rocapine does
Rocapine specializes in developing and scaling wellness applications that aim to foster healthier habits and improve daily life for users. The company’s core philosophy revolves around creating products that “hold instead of hook,” emphasizing lasting value and user wellbeing over mere engagement metrics. Rocapine employs AI-driven tools in its approach to prioritize the overall health of its users. The company has already launched several applications, addressing areas such as women’s health, addiction therapy, and nutrition. Specific examples include Harmony, which focuses on cycle tracking and women’s wellbeing; That Girl, designed to assist users in building healthier routines; and Unchaind, an app aimed at helping individuals overcome compulsive behaviors.
What the funding will do
The EUR 11.2 million Series A funding will be strategically deployed to support Rocapine’s next phase of growth. The primary objective for the capital is to scale its portfolio of wellness apps. This includes transforming its initial successful applications into leaders within their respective categories. A significant portion of the investment will also be directed towards expanding its testing engine, with an ambitious target of scaling to 400 apps this year. Furthermore, Rocapine plans to strengthen the underlying infrastructure of its portfolio, specifically enhancing its AI, data, and marketing capabilities.
Why it matters
This funding round for Rocapine highlights a growing focus within the health app sector on digital wellbeing and sustainable user engagement. In an era where smartphone usage is extensive, and concerns about technology’s impact on mental and physical health are prevalent, companies like Rocapine are addressing a critical need. By developing apps designed to deliver tangible benefits and integrate positively into daily routines, rather than simply maximizing screen time, Rocapine is positioning itself within a sub-sector that prioritizes user health outcomes. This investment signals continued confidence in models that aim to leverage technology for genuine, long-term wellness improvements.